2025-04-08 18:31:37
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Strides Pharma Science Ltd Q4FY22 consolidated PAT at Rs. 29.21 crores
Posted On : 2022-05-25 11:43:24( TIMEZONE : IST )
Strides Pharma Science Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 952.075 crores during the period ended March 31, 2022 as compared to Rs. 804.582 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 29.219 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. -121.671 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 3.25 for the period ended March 31, 2022 as compared to Rs. -13.55 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 952.075 crs | ₹804.582 crs |  18.33% |
| Net Profit | ₹29.219 crs | ₹-121.671 crs | 124.01% |
| EPS | ₹3.25 | ₹-13.55 | 123.99% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 952.075 crores during the period ended March 31, 2022 as compared to Rs.921.541 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.29.219 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.46.086 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.3.25 for the period ended March 31, 2022 as compared to Rs.5.14 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 952.075 crs | ₹921.541 crs | 3.31% |
| Net Profit | ₹29.219 crs | ₹46.086 crs |  -36.60% |
| EPS | ₹3.25 | ₹5.14 | -36.77% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.3202.238 crores during the Financial Year ended March 31, 2022 as compared to Rs.3367.297 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-460.211 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.268.442 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.-51.28 for the Financial Year ended March 31, 2022 as compared to Rs.29.92 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹3202.238 crs | ₹3367.297 crs | -4.90% |
| Net Profit | ₹-460.211 crs | ₹268.442 crs | -271.44% |
| EPS | ₹-51.28 | ₹29.92 | -271.39% |
Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 302.70 as compared to the previous close of Rs. 307.05. The total number of shares traded during the day was 20581 in over 1032 trades.
The stock hit an intraday high of Rs. 307.35 and intraday low of 297.60. The net turnover during the day was Rs. 6243128.00.
